![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, October 03, 2000 6:02:31 AM
We have developed unique and comprehensive SNP databases through the use of proprietary
data mining techniques. Our work has so far resulted in two distinct databases, one for cancer
predisposition screening and the other for drug interactivity screening. Our databases are fully
annotated, and contain relevant LocusLink, Medline, UniGene, Entrez, and PubMed
information. What makes our database even more unique is that it contains flanking sequence
5’ and 3’ for each target SNP which enables rapid application to microchip based screening
platforms. The data and annotation that we have compiled does not currently exist in any NCBI
or other public database, and we currently enjoy their exclusive use.
http://www.dnaprint.com./index.cfm?fuseaction=content&id=27
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM